Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Head Neck. 2020 Jun 9;42(9):2542–2554. doi: 10.1002/hed.26286

Table 1C).

NA cells treated with ciglitazone, percentage of cells in each cell cycle phase in duplicate assays

Condition
(μM)
G1 S G2
Control 89.2 89.2 9.4 9.4 1.5 1.5
C5 79.4 86.7 18 12.5 2.7 0.81
C10 80.6 84.9 15.1 10 4.4 5.1